Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Diethylthiambutene is a synthetic opioid analgesic developed in the 1950s, primarily used as an anesthetic in veterinary medicine. It belongs to the thiambutene class of opioids and is structurally related to methadone. Its main use has been for anesthesia in animals, particularly in Japan. Diethylthiambutene acts as an agonist at opioid receptors, producing analgesia and sedation typical of opioids. Due to its high potential for abuse and lack of accepted medical use in humans, it is classified as a Schedule I controlled substance under both US law and international conventions[1][2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on diethylthiambutene.